A recent @natmachintell.nature.com paper by our cofounder-CTO @victorgreiff.bsky.social shows models trained on harder antibody binding tasks learned better, boosting antibody ML generation.

At IMPRINT, this mindset drives our push for robust AI-based mapping of adaptive immunity.

#Immunology #AI

Our CEO & Co-Founder @beckbrachman.bsky.social spoke at @mofollp.bsky.social #MoForum in NYC on how AI/ML is reshaping immunology and the opportunities ahead for life sciences — alongside amazing innovators! 🧠

#MachineLearning #Immunology #AIForScience #AntibodyDiscovery

Models trained on harder antibody binding tasks learned deeper biological rules + generalized better.

New NatureMachIntel paper by CTO @victorgreiff.bsky.social shows training on hard negatives (weak vs strong binders) boosts antibody ML generalization.

Read the paper: doi.org/10.1038/s422...

Earlier this year, Imprint came out of stealth on the TED Mainstage to share our vision:

What if the immune system holds the key to curing chronic diseases—and we just need the tools to read it?

We’re building those tools.
Our TED talk is now live 👉 go.ted.com/beckbrachman

IMPRINT is #hiring a COO to help shape our work at the intersection of #immunology, machine learning, and neuroscience! The COO will guide product strategy/development, build a community of users and partners, and scale Imprint from early-stage R&D to market readiness, entry, and growth.

New: @cornelltech.bsky.social's article on IMPRINT’s journey from incubation to last week’s launch, w/ grant funding from the NYC Economic Development Corporation’s LifeSci Initiative. The crucial support offered by both of these organizations makes our work at IMPRINT possible.

📣Major thanks to @faylinphd.bsky.social at GEN News for this lovely piece on IMPRINT! It was a pleasure for our founders — @beckbrachman.bsky.social, @victorgreiff.bsky.social, and Raymond Alvarez — to speak about our mission and research, and being NYC's first FRO.

@convergentresearch.bsky.social

I could not be prouder to publicly announce IMPRINT, a pioneering new non-profit to decode the body's immune memory and uncover the causes of chronic diseases. I’m joined in this journey by a brilliant and dedicated team of scientists from Europe and N. America.

Excited to co-found and help lead @imprintlabs.bsky.social —a focused effort to decode the immune system’s memory through cutting-edge computation and experimentation. Grateful to be on this journey with an exceptional team.

🧵 Today, IMPRINT, a pioneering new nonprofit initiative, is announcing $15 million in philanthropic funding to advance our work to decode the body's immune memory and uncover the causes of chronic diseases.

#Immunology #Biotech #BiotechResearch

Looking for a job in immunology or biotech research?
✨IMPRINT is #hiring! ✨

Join us to help revolutionize how we decode the body’s immune memory, uncover the causes of chronic diseases, and drive breakthroughs in autoimmunity and neuropsychiatric research.

#BiotechJobs #Immunology #sciencejobs

It's an exciting moment for immune repertoire research! At the end of December in Cell Systems, we shared our perspective on recent advances in ML for immune repertoire interpretation: www.sciencedirect.com/science/arti...